id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2014-N-1721-0023,FDA,FDA-2014-N-1721,Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals,Notice,Notice of Approval,2023-10-18T04:00:00Z,2023,10,2023-10-18T04:00:00Z,,2023-10-18T15:03:32Z,2023-23002,0,0,09000064861047b6
FDA-2014-N-1721-0022,FDA,FDA-2014-N-1721,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Investigational New Drug Application Requirements,Notice,30 Day Proposed Information Collection,2023-08-08T04:00:00Z,2023,8,2023-08-08T04:00:00Z,2023-09-08T03:59:59Z,2023-08-08T13:51:09Z,2023-16923,0,0,0900006485dfb7aa
FDA-2014-N-1721-0021,FDA,FDA-2014-N-1721,"Agency Information Collection Activities; Proposed Collection; Comment Request; Investigational
New Drug Application Requirements",Notice,60 Day Proposed Information Collection,2023-04-11T04:00:00Z,2023,4,2023-04-11T04:00:00Z,2023-06-13T03:59:59Z,2023-04-11T14:31:17Z,2023-07529,0,0,090000648592c0c0